Nova Eye Medical Limited (EYE.AX)
AUD 0.11
(0.0%)
AUD 0.11
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 8.55 Million AUD | 19.34% |
| 2023 | 7.16 Million AUD | 15.06% |
| 2022 | 6.22 Million AUD | -6.47% |
| 2021 | 6.65 Million AUD | -58.78% |
| 2020 | 16.15 Million AUD | -48.05% |
| 2019 | 31.09 Million AUD | 2.9% |
| 2018 | 30.22 Million AUD | 2.07% |
| 2017 | 29.6 Million AUD | 24.76% |
| 2016 | 23.73 Million AUD | 23.7% |
| 2015 | 19.18 Million AUD | 11.04% |
| 2014 | 17.27 Million AUD | 4.61% |
| 2013 | 16.51 Million AUD | 28.3% |
| 2012 | 12.87 Million AUD | -28.72% |
| 2011 | 18.06 Million AUD | -1.8% |
| 2010 | 18.39 Million AUD | -11.81% |
| 2009 | 20.85 Million AUD | -13.11% |
| 2008 | 24 Million AUD | 18.19% |
| 2007 | 20.3 Million AUD | 79.2% |
| 2006 | 11.33 Million AUD | 12.59% |
| 2005 | 10.06 Million AUD | 28.45% |
| 2004 | 7.83 Million AUD | 20.83% |
| 2003 | 6.48 Million AUD | -18.56% |
| 2002 | 7.96 Million AUD | 2138.06% |
| 2001 | 355.8 Thousand AUD | 77.09% |
| 2000 | 200.91 Thousand AUD | 318.16% |
| 1999 | 48.04 Thousand AUD | 9.86% |
| 1998 | 43.73 Thousand AUD | -51.97% |
| 1997 | 91.06 Thousand AUD | 94.34% |
| 1996 | 46.85 Thousand AUD | 112.99% |
| 1995 | 22 Thousand AUD | -12.0% |
| 1994 | 25 Thousand AUD | -57.63% |
| 1993 | 59 Thousand AUD | -42.72% |
| 1992 | 103 Thousand AUD | 0.98% |
| 1991 | 102 Thousand AUD | -78.02% |
| 1990 | 464 Thousand AUD | 122.01% |
| 1989 | 209 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 8.55 Million AUD | 0.0% |
| 2024 Q2 | 6.85 Million AUD | 0.0% |
| 2024 FY | 8.55 Million AUD | 19.34% |
| 2023 Q4 | 7.16 Million AUD | 0.0% |
| 2023 FY | 7.16 Million AUD | 15.06% |
| 2023 Q2 | 6.22 Million AUD | 0.0% |
| 2022 Q2 | 4.47 Million AUD | 0.0% |
| 2022 FY | 6.22 Million AUD | -6.47% |
| 2022 Q4 | 6.22 Million AUD | 0.0% |
| 2021 Q2 | 14.53 Million AUD | 0.0% |
| 2021 FY | 6.65 Million AUD | -58.78% |
| 2021 Q4 | 6.65 Million AUD | 0.0% |
| 2020 Q4 | 16.15 Million AUD | 0.0% |
| 2020 Q2 | 32.15 Million AUD | 0.0% |
| 2020 FY | 16.15 Million AUD | -48.05% |
| 2019 Q4 | 31.09 Million AUD | 0.0% |
| 2019 Q2 | 33.82 Million AUD | 0.0% |
| 2019 FY | 31.09 Million AUD | 2.9% |
| 2018 FY | 30.22 Million AUD | 2.07% |
| 2018 Q4 | 30.22 Million AUD | 0.0% |
| 2018 Q2 | 28.32 Million AUD | 0.0% |
| 2017 FY | 29.6 Million AUD | 24.76% |
| 2017 Q2 | 26.69 Million AUD | 0.0% |
| 2017 Q4 | 29.6 Million AUD | 0.0% |
| 2016 Q4 | 23.73 Million AUD | 0.0% |
| 2016 FY | 23.73 Million AUD | 23.7% |
| 2016 Q2 | 17.92 Million AUD | 0.0% |
| 2015 FY | 19.18 Million AUD | 11.04% |
| 2015 Q4 | 19.18 Million AUD | 0.0% |
| 2015 Q2 | 19.71 Million AUD | 0.0% |
| 2014 Q2 | 14.7 Million AUD | 0.0% |
| 2014 Q4 | 17.27 Million AUD | 0.0% |
| 2014 FY | 17.27 Million AUD | 4.61% |
| 2013 Q4 | 16.51 Million AUD | 0.0% |
| 2013 FY | 16.51 Million AUD | 28.3% |
| 2013 Q2 | 12.97 Million AUD | 0.0% |
| 2012 FY | 12.87 Million AUD | -28.72% |
| 2012 Q4 | 12.87 Million AUD | 0.0% |
| 2011 Q4 | 18.06 Million AUD | 0.0% |
| 2011 FY | 18.06 Million AUD | -1.8% |
| 2010 FY | 18.39 Million AUD | -11.81% |
| 2010 Q4 | 18.39 Million AUD | 0.0% |
| 2009 Q4 | 20.85 Million AUD | 0.0% |
| 2009 FY | 20.85 Million AUD | -13.11% |
| 2008 Q4 | 24 Million AUD | 0.0% |
| 2008 FY | 24 Million AUD | 18.19% |
| 2007 FY | 20.3 Million AUD | 79.2% |
| 2007 Q4 | 20.3 Million AUD | 0.0% |
| 2006 FY | 11.33 Million AUD | 12.59% |
| 2006 Q4 | 11.33 Million AUD | 0.0% |
| 2005 Q4 | 10.06 Million AUD | 0.0% |
| 2005 FY | 10.06 Million AUD | 28.45% |
| 2004 Q4 | 7.83 Million AUD | 0.0% |
| 2004 FY | 7.83 Million AUD | 20.83% |
| 2003 Q4 | 6.48 Million AUD | 0.0% |
| 2003 FY | 6.48 Million AUD | -18.56% |
| 2002 FY | 7.96 Million AUD | 2138.06% |
| 2002 Q4 | 7.96 Million AUD | 0.0% |
| 2001 Q4 | 355.8 Thousand AUD | 0.0% |
| 2001 FY | 355.8 Thousand AUD | 77.09% |
| 2000 Q4 | 200.91 Thousand AUD | 0.0% |
| 2000 FY | 200.91 Thousand AUD | 318.16% |
| 1999 Q4 | 48.04 Thousand AUD | 0.0% |
| 1999 FY | 48.04 Thousand AUD | 9.86% |
| 1998 Q4 | 43.73 Thousand AUD | 0.0% |
| 1998 FY | 43.73 Thousand AUD | -51.97% |
| 1997 Q4 | 91.06 Thousand AUD | 0.0% |
| 1997 FY | 91.06 Thousand AUD | 94.34% |
| 1996 FY | 46.85 Thousand AUD | 112.99% |
| 1995 FY | 22 Thousand AUD | -12.0% |
| 1994 FY | 25 Thousand AUD | -57.63% |
| 1993 FY | 59 Thousand AUD | -42.72% |
| 1992 FY | 103 Thousand AUD | 0.98% |
| 1991 FY | 102 Thousand AUD | -78.02% |
| 1990 FY | 464 Thousand AUD | 122.01% |
| 1989 FY | 209 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | 82.579% |
| Adherium Limited | 3.4 Million AUD | -151.03% |
| Aroa Biosurgery Limited | 14.77 Million AUD | 42.133% |
| Atomo Diagnostics Limited | 1.29 Million AUD | -560.696% |
| Anteris Technologies Ltd | 17.03 Million AUD | 49.81% |
| Control Bionics Limited | 2.75 Million AUD | -209.9% |
| CardieX Limited | 8.56 Million AUD | 0.12% |
| Compumedics Limited | 22.14 Million AUD | 61.387% |
| Cochlear Limited | 904.6 Million AUD | 99.055% |
| CleanSpace Holdings Limited | 6.94 Million AUD | -23.055% |
| Cyclopharm Limited | 13.65 Million AUD | 37.37% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | -56.755% |
| HeraMED Limited | 1.5 Million AUD | -467.885% |
| Imricor Medical Systems, Inc. | 25 Million AUD | 65.798% |
| ImpediMed Limited | 6.24 Million AUD | -36.985% |
| InhaleRx Limited | 911.41 Thousand AUD | -838.323% |
| LBT Innovations Limited | 5.5 Million AUD | -55.265% |
| Micro-X Limited | 12.63 Million AUD | 32.31% |
| Neurotech International Limited | 314.69 Thousand AUD | -2617.517% |
| OncoSil Medical Limited | 1.98 Million AUD | -331.485% |
| PolyNovo Limited | 37.04 Million AUD | 76.913% |
| Respiri Limited | 3.55 Million AUD | -140.632% |
| SomnoMed Limited | 24.78 Million AUD | 65.489% |
| Universal Biosensors, Inc. | 10.61 Million AUD | 19.416% |
| Uscom Limited | 2.07 Million AUD | -312.428% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | -209.081% |